Early bird fees for our new Active Substance Course and Clinical Trials course being run next Tuesday- 23rd June, 20th of July and 11th of August will be applied to bookings made within a week of the course.
Shankar Seetharaman is a Qualified Person with many years of experience in API auditing and clinical trials supply. He currently is the Managing Director of Pharmanswers Ltd which is a consultancy with a proven track record of providing quality and regulatory support for the pharmaceutical industry…
More trade is essential if the UK is to overcome the unprecedented economic challenge posed by the Coronavirus. The UK’s priority is to launch negotiations with the EU, the US, Australia, New Zealand and Japan…
UK government will not be extending the transition period, which means The transition period will, therefore, end on 31 December 2020, in line with the provisions of the Withdrawal Agreement. New rules will take effect on 1 January 2021…
We are all looking forward to having our lives back to normal. But will it be normal again?
The R number will be closely monitored as lockdown is relaxed and it involves lots of complex mathematics to determine the number, however the number of people dying will be a major factor…
Try the 6 Ws and the 6 Hs (W>W>H>H>W>W>H>H>W>W>H>H)…
The scheme that NHS England launched to enable volunteers to deliver pharmacy medicines may result in prosecution if there is a fatal misstate made or bad advice given. The patient might ask “how do I take these?” Or “are these safe with my other medicines? The medicine could be diverted or delivered to the wrong door…
There is a lot of talk about measuring blood oxygen saturation at home using pulse oximeters to give early warning of COVID-19 symptoms and to allow the early presentation at hospital. If testing at home, you need to know what is normal and ideally the testing should be part of a management plan and under the supervision of a healthcare professional…
In March, Public Health England announced that Coronavirus ‘home’ testing kits were not approved and there was no evidence to suggest the efficacy of such tests…
